EXEMESTAN ACTAVIS 25 MG

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Ingredientes activos:

EXEMESTANE

Disponible desde:

DEVRIES & CO. LTD

Código ATC:

L02BG06

formulario farmacéutico:

FILM COATED TABLETS

Composición:

EXEMESTANE 25 MG

Vía de administración:

PER OS

tipo de receta:

Required

Fabricado por:

S.C SINDAN-PHARMA S.R.L (FOR ACTAVIS GROUP PTC EHF, ICELAND), ROMANIA

Área terapéutica:

EXEMESTANE

indicaciones terapéuticas:

Treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. Treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies. Adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Fecha de autorización:

2016-07-10